Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
headphones
Pharma Market Access Insights - from Petauri Evidence

Pharma Market Access Insights - from Petauri Evidence

Petauri Evidence

We explore news and insights from global healthcare markets, advising how pharma and medtech need to respond and adapt their market access strategy in light of the latest insights from our experts. The podcast features insights from our associates across global healthcare, along with thought leadership from the market access and HEOR experts at Petauri Evidence.

Share icon

All episodes

Best episodes

Seasons

Top 10 Pharma Market Access Insights - from Petauri Evidence Episodes

Goodpods has curated a list of the 10 best Pharma Market Access Insights - from Petauri Evidence episodes, ranked by the number of listens and likes each episode have garnered from our listeners. If you are listening to Pharma Market Access Insights - from Petauri Evidence for the first time, there's no better place to start than with one of these standout episodes. If you are a fan of the show, vote for your favorite Pharma Market Access Insights - from Petauri Evidence episode by adding your comments to the episode page.

Pharma Market Access Insights - from Petauri Evidence - The evolving NHS: How can Pharma and Medtech support the NHS in 2022?  - NHS Insights Panel Discussion
play

01/17/22 • 62 min

Pharma and Medtech professionals put questions to our panel of NHS associates as we reflected on the operational, structural, and clinical challenges the NHS has faced in 2021 and how Pharma and Medtech can best support the NHS in 2022.
We were joined by some of Mtech Access’s closest and most insightful friends:
- David Thorne (Director, Mtech Access and Well Up North PCN) our Policy expert
- Patrick McGinley (Head of Costing and Service Line Reporting, Maidstone and Tunbridge Wells NHS Trust) our Hospitals and Finance expert
- Liz Cross (Advanced Nurse Practitioner, Attenborough Surgery, Watford) our Primary Care and Clinical expert
- Ewan Maule (Interim Chief Pharmacist, North East and North Cumbria ICS) our System and Medicines expert
This podcast was originally broadcast as a live webinar on 10th December 2021.
Learn more at https://mtechaccess.co.uk/evolving-nhs-pharma-medtech-support-2022/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

bookmark
plus icon
share episode
Pharma Market Access Insights - from Petauri Evidence - Market access for digital therapies and digital medicines

Market access for digital therapies and digital medicines

Pharma Market Access Insights - from Petauri Evidence

play

07/19/23 • 42 min

In this Global Whispers webinar we explore market access for digital therapeutics. Clare Foy (Global Market Access Director – Mtech Access) speaks to Shefali Shah (Global VP, Market Value and Commercial Effectiveness – MindMaze) about the challenges and opportunities for digital therapies to gain market access and ultimately improve patient outcomes.
In the webinar, Clare asks Shefali about:

  • The opportunities for digital technologies in neurology and how they may impact existing care pathways in the future
  • How the digital technology market differs from the pharmaceutical market
  • Regulatory and reimbursement challenges for digital technologies
  • Her experiences in launching digital technologies in markets such as the US and Germany
  • How digital technologies can be used to enhance and complement existing treatments/pathways of care
  • Lessons other digital health, medical device and pharmaceutical companies can learn from Shefali’s experiences

The episode was first broadcast as a live webinar in June 2023. Learn more about this webinar at https://mtechaccess.co.uk/market-access-for-digital-therapies/
Learn how Mtech Access can support you with your market access journey at: https://mtechaccess.co.uk/global-market-access-and-pricing/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

bookmark
plus icon
share episode
Pharma Market Access Insights - from Petauri Evidence - The Evolving NHS - Lessons for Pharma and Medtech  - NHS insights webinar with David Thorne and Tom Clarke
play

10/09/20 • 61 min

From capacity management to changing performance measures, discover what’s changing in the NHS, the impact on the NHS long-term plan and what all this means for the future of market access. Tom Clarke and David Thorne, from the Mtech Access NHS Insights & Interaction team, review some of the insights from our earlier series: ‘How is COVID-19 impacting the NHS?’, as well as exploring trends and challenges uncovered in conversation with our network of NHS Associates in our first 'Whispers Words of Wisdom' podcast.
Tom and David begin by reflecting on what has changed in the NHS over 2020 and how this has evolved over time. They explore how the NHS response to the pandemic has impacted long-term plan priorities, particularly in the light of the recently published Evidence Based Interventions Engagement document (from http://www.aomrc.org.uk/ebi/).

Tom and David also discuss cooperation, collaboration and capacity management both within the NHS and with the independent sector. They consider how quickly hospitals and primary care will be able to clear the backlog of patients and the measures that might be brought in to enable this.

Taking all of this into consideration, David and Tom discuss how the pharma and medtech industries can support the NHS at this time and how these changes may impact the future of market access. For example, they explore how changes to performance measures may affect future economic models and how economic evaluations could be made more relevant to local commissioning decisions.
This episode was originally broadcast on 31st July 2020 as a webinar.
Learn more about our NHS insights services at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

bookmark
plus icon
share episode
Pharma Market Access Insights - from Petauri Evidence - The hidden heroes of the NHS - The role of ambulance Trusts in keeping patients and systems moving
play

07/06/21 • 59 min

What role do Ambulance Trusts play in the success of the wider NHS? How might urgent and community care evolve as we head to integration as part of a joined-up system? How will an integrated ambulance service support system redesign to keep people out of hospital, and provide more proactive care to those who need it most?

Helen Ray (Chief Executive of North East Ambulance Service NHS Foundation Trust) joins Tom Clarke (Director, Mtech Access) to discuss the role Ambulance Trusts play in delivering care. This role far exceeds attending 999 calls. We explored the important role Ambulance Trusts play in keeping people out of hospital and in instigating new models of care. They are the first point of contact for many clinical events, both on the ground and through their role in NHS 111.

As such, Ambulance Trusts understand first-hand the real drivers for accessing health services. Helen Ray, as Chief Executive of North East Ambulance Service NHS Foundation Trust is ideally placed to open a window to their world and explore what a more integrated future may mean for emergency care and the wider health system.

Helen Ray joined North East Ambulance Service in 2019, following 36 years’ experience in various roles across the NHS. Helen was previously Chief Operating Officer at Northumbria Healthcare NHS Foundation Trust, where she oversaw urgent and emergency care, medicine, child health, and community services with Board level responsibility and emergency planning and preparedness. She has also previously been Joint Managing Executive Director (operations) for North Cumbria acute and community services; Deputy Chief Executive for North Cumbria University Hospitals; and Chief Operating Officer for South Tyneside NHS Foundation Trust. She trained as a nurse and has held a professional registration for 30 years.

This episode was first broadcast as a live webinar on Friday 25th June 2021.
Learn more about our NHS insights services at https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

bookmark
plus icon
share episode
Pharma Market Access Insights - from Petauri Evidence - Know your Place - where will power really sit in the new NHS - with Dr Steven Michael OBE
play

05/17/21 • 61 min

What will a ‘Place’ look like? What will this new layer of the NHS mean in practice and what decision-making powers will Place leaders have?

As the NHS starts its journey towards an integrated future, Dr Steven Michael OBE (Chair of East Cheshire Partnership) joins Tom Clarke (Director, Mtech Access) to talk ‘Place’, ‘Partnership’, ’Collaboratives’ and more.
The UK Government’s Health and Care White Paper, along with other recent policy announcements, set out a major proposed reorganisation of the NHS in England. This includes the introduction of the term ‘Place’, a localised function within Integrated Care Systems (ICSs). There is still much uncertainty, even within the NHS, about what this term and others like ‘Collaborative’ will mean in practice.

In this episode, Tom and Steven discuss what these new structures mean, how they may affect the patient experience, how they will impact decision-making and what they could mean for pharmaceutical and medtech market access.

Dr Steven Michael OBE has over 20 years of experience in the NHS. He began his career as a registered nurse working in psychiatric intensive care in 1985, before rising through various management and leadership roles to be CEO of a South West Yorkshire Partnership NHS FT between 2007 and 2016. He has since contributed to or chaired a number of NHS boards, including the NHS Confederation’s Mental Health Network, Spectrum Community Health CIC and East Cheshire Partnership.
This episode was first broadcast as a live webinar on 30th April 2021.
Learn more about our NHS insights services at https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

bookmark
plus icon
share episode
Pharma Market Access Insights - from Petauri Evidence - Population to person - How will the voice of the individual drive health and care development?
play

06/02/21 • 61 min

Population health management is often talked about in top-down terms, but how seriously will the needs of individuals be taken as systems develop? How will personal needs inform care delivery? Why will the patient voice play a very different role in the NHS of the future?
Steph Edusei (Chief Executive of St Oswald’s Hospice) joins Tom Clarke (Director, Mtech Access) to explore these questions and more.
This episode was first released as a live webinar on Friday 21st May 2021.
For more information visit: https://www.mtechaccess.co.uk/population-health-development-webinar/
Steph Edusei has held the role of Chief Executive at St Oswald’s Hospice since May 2020. The hospice provides specialist care for adults, babies, children and young adults from across the North East of England and takes a proactive approach to integrated care, working with other NHS providers in the region and the wider population.

Prior to this, Steph was Chief Executive of Tell us North, the organisation that run Healthwatch Newcastle and Healthwatch Gateshead, giving her extensive experience in local healthcare and how this integrates with wider NHS systems. She has also held a wide variety of leadership and senior operational positions, including Interim Deputy Chief Executive at Newcastle Council for Voluntary Services; Authorisation Development lead and then Strategic Head of Corporate Affairs at NHS Northumberland Clinical Commissioning Group (CCG); Assistant Director, Commissioning at NHS North of Tyne, and Assistant Director of Operations at North East Ambulance Service NHS Trust. Rarely does one come across an individual with such a breadth of experience across so many different services supporting population health.
Learn more about our NHS insights services at https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

bookmark
plus icon
share episode
Pharma Market Access Insights - from Petauri Evidence - Questions Time Special - Views from across the NHS; from costings to strategy to clinical care
play

07/30/20 • 62 min

In this 'Questions Time' special we welcome a broad panel of practitioners from across the NHS to explore the themes of care delivery, collaboration, innovation and governance. Our panellists are:

  • Cameron Ward (Interim Director of Strategy and Outcomes, Sefton CCG)
  • Hilary Snowdon (Management Lead, West Northumberland PCN)
  • Patrick McGinley (Head of Costing & SLR, Maidstone & Tunbridge Wells NHS Trust)
  • Dr Su McCole (GP & Area Clinical Director)

This episode is part of our COVID-19 series, where Tom Clarke (Director - NHS Insights & Interaction, Mtech Access) asks experts holding operational, strategic and clinical roles across the NHS to share their experiences and insights into how the NHS has responded to COVID-19 and the wider challenges facing the health service.
In this special 1-hour episode, our panellists explore:
Care delivery:

  • What will happen to elective procedures over the next few months - how will they be prioritised & delivered?
  • How will services begin to mobilise themselves while the threat of a second (and subsequent) wave remains?


Collaboration:

  • What are the highlights you have seen locally in approaches to collaborative working?
  • Do you think trust has been built in partnership working that will continue post COVID, both within the NHS and with external partners?
  • What has been your experience of working with the pharmaceutical industry during this COVID pandemic?

Innovation:

  • How will innovations that have happened during COVID be evaluated so the best ones are kept?
  • What elements of the remote care used, evolved or developed during the pandemic will become standard elements of NHS care, and in what time frame?
  • What risks are attached with the innovations we have seen during COVID?


Governance:

  • What lasting ‘relaxation’ effects on NHS governance (engagement; medicine trials; budgets etc.) do you anticipate as remaining post pandemic?
  • What part do you expect the NHS to play in covering the ‘COVID bill’ that the country has been left with?

This episode was originally broadcast on 5th June 2020 as a webinar. This podcast series has been converted from our webinar series 'How is COVID-19 impacting the NHS?'.
Learn more about our NHS insights services at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

bookmark
plus icon
share episode
Pharma Market Access Insights - from Petauri Evidence - Engage NHS healthcare decision-makers with RWD

Engage NHS healthcare decision-makers with RWD

Pharma Market Access Insights - from Petauri Evidence

play

08/12/24 • 20 min

Discover how data visualisation dashboards can aid field teams in market access discussions with customers.
Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with RWD within a well-designed, easy-to-use visualisation can build a case for change, while positioning themselves as a trusted partner. Watch this 20-minute discussion between Iain Shield (Associate Director – Market Access) and Ben Spurr (Head of Partnerships) to discover how Connected Insights data visualisation dashboards can help your teams have strategic conversations with healthcare decision-makers. Iain also explains typical use cases for the dashboards for field teams, why data dashboards are useful for the NHS, and what sets Connected Insights dashboards apart.
Learn more about this showcase at: https://mtechaccess.co.uk/engage-nhs-with-rwd/
Learn more about real-world data visualisation at: https://mtechaccess.co.uk/digital-capabilities/real-world-data-market-access/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

bookmark
plus icon
share episode
Pharma Market Access Insights - from Petauri Evidence - NHS policy for 2024/25: strategy and engagement in a world of uncertainty (recorded in Jan 2024)
play

04/09/24 • 62 min

What do we know about plans and policy for 2024/25? As the expected central operating plan had not materialised (at time of recording), and with a general election and a potential Labour government on the horizon, how can NHS and industry drive forward improvements and innovation?
Host Robert Hull (Senior Consultant – NHS Insight & Interaction, Mtech Access) was joined by guest speakers Debbie Morgan (Director of Service Improvement and Transformation, Cambridge University Hospitals NHS Foundation Trust), Ellen Rule (Deputy CEO/Director of Strategy & Transformation, Gloucestershire Integrated Care Board) and Dr Viren Mehta (GP Partner, GP Federation Chief Officer, Viaduct Care). Together we explored what all this uncertainty means for NHS decision-making, day-to-day operations, strategy, and engagement with industry.
In this webinar, we bring together leaders from across the NHS to explore how they are planning and operating in this uncertainty.
We explore:
- Strategy and planning in these times of uncertainty
- What’s happening with GP contracts
- Financial pressures and challenges
- If/where it’s possible to drive forward change in the current environment
- How Pharma and Medtech can best support NHS leaders
- Where the panel would welcome solutions from industry
Please note this episode was first broadcast in January 2024 as a live webinar. Some aspects of policy discussed have evolved and continue to evolve.
Discover more at: https://mtechaccess.co.uk/nhs-policy-for-2024-25/
Learn more about our NHS insights services at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

bookmark
plus icon
share episode
Pharma Market Access Insights - from Petauri Evidence - Healthcare, economics and society – unlocking NHS collaboration

Healthcare, economics and society – unlocking NHS collaboration

Pharma Market Access Insights - from Petauri Evidence

play

01/30/23 • 59 min

Will NHS leaders, as part of an Integrated Care System (ICS), make conscious decisions to drive economic and social change?
What social and economic value do ICSs offer the wider population they serve? How will industry support ICSs to deliver population-based health and social benefits?

Prof Phil Richardson (Chair and Chief Innovation Officer, Mtech Access) is joined by Michael Wood (Head of Health Economic Partnerships, NHS Confed) for a far-reaching discussion around system integration, population health management, and the NHS’s social and economic potential.
In December (2022), Michael Wood authored a report exploring one of the four key purposes of an ICS: to help the NHS support broader social and economic development. Michael’s NHS Confed report looked at the economics of healthcare and where broader strategic partnership working might lead system thinking in the NHS.
Phil Richardson was one of several experienced ICS, local authority, university and professional experts that Michael invited to share their perspectives in the report.
We were delighted to bring Michael and Phil together in this webinar to discuss these topics, particularly in light of what these new leadership purposes mean for the NHS’s relationship with the Pharmaceutical and wider Life Science industries.
In the webinar, Phil and Michael discuss:

  • NHS Confed and the links between the health sector and the economy
  • The need for ICS leaders to focus on broader social and economic development
  • How Pharma and Medical Device companies can add value to support this key ICS purpose
  • Why health and economic development is key to tackling health inequalities
  • The important role the NHS plays as an anchor institution that links better health with economic and social development
  • What health and economic development could mean for funding at different levels of an integrated system – e.g. place based commissioning
  • Opportunities for industry to step up and support the NHS with economic and social development

Learn more about this webinar here
Learn more about our work with the NHS
This episode was first broadcast as a live webinar in January 2023

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

bookmark
plus icon
share episode

Show more best episodes

Toggle view more icon

FAQ

How many episodes does Pharma Market Access Insights - from Petauri Evidence have?

Pharma Market Access Insights - from Petauri Evidence currently has 65 episodes available.

What topics does Pharma Market Access Insights - from Petauri Evidence cover?

The podcast is about Life Sciences, Pharma, Podcasts, Science, Business, Pharmaceutical and Healthcare.

What is the most popular episode on Pharma Market Access Insights - from Petauri Evidence?

The episode title 'Digital value payer communication tools: How to meet the needs of your internal stakeholders and customers' is the most popular.

What is the average episode length on Pharma Market Access Insights - from Petauri Evidence?

The average episode length on Pharma Market Access Insights - from Petauri Evidence is 53 minutes.

How often are episodes of Pharma Market Access Insights - from Petauri Evidence released?

Episodes of Pharma Market Access Insights - from Petauri Evidence are typically released every 25 days, 23 hours.

When was the first episode of Pharma Market Access Insights - from Petauri Evidence?

The first episode of Pharma Market Access Insights - from Petauri Evidence was released on Jun 2, 2020.

Show more FAQ

Toggle view more icon

Comments